Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study

E Bruckert, G Hayem, S Dejager, C Yau… - … drugs and therapy, 2005 - Springer
Objectives: To characterize the risk factors, rate of occurrence, onset, nature and impact of
mild to moderate muscular symptoms with high-dosage HMG-CoA reductase inhibitor (statin) …

[HTML][HTML] Anakinra for severe forms of COVID-19: a cohort study

…, JJ Mourad, G Chatellier, G Hayem - The Lancet …, 2020 - thelancet.com
Background Coronaviruses can induce the production of interleukin (IL)-1β, IL-6, tumour
necrosis factor, and other cytokines implicated in autoinflammatory disorders. It has been …

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS)

…, B Sauvezie, A Perdriger, G Hayem… - … : Official Journal of …, 2004 - Wiley Online Library
Objective. There is no effective treatment for patients with primary Sjögren’s syndrome (SS).
Since tumor necrosis factor (TNF) could be a key element in the pathogenesis of primary SS, …

SAPHO syndrome: a long-term follow-up study of 120 cases

G Hayem, A Bouchaud-Chabot, K Benali… - Seminars in arthritis and …, 1999 - Elsevier
OBJECTIVE:: To assess the long-term outcome of the synovitis, acne, pustulosis, hyperostosis,
osteitis (SAPHO) syndrome. METHODS:: All patients with the SAPHO syndrome seen at …

Treatment of primary Sjögren syndrome with rituximab: a randomized trial

…, E Hachulla, PY Hatron, V Goeb, G Hayem… - Annals of internal …, 2014 - acpjournals.org
Background: Primary Sjögren syndrome (pSS) is an autoimmune disorder characterized by
ocular and oral dryness or systemic manifestations. Objective: To evaluate efficacy and …

[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

…, EJ Giamarellos-Bourboulis, G Hayem… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial

…, A Saraux, V Devauchelle-Pensec, J Morel, G Hayem… - Jama, 2014 - jamanetwork.com
Importance Primary Sjögren syndrome is a systemic autoimmune disease characterized by
mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently …

[HTML][HTML] A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites

…, C Dewas, Y Kroviarski, G Hayem… - The Journal of …, 2006 - Am Soc Clin Investig
Neutrophil NADPH oxidase plays a key role in host defense and in inflammation by releasing
large amounts of superoxide and other ROSs. Proinflammatory cytokines such as GM-CSF …

Vasculitides associated with malignancies: analysis of sixty patients

…, I Delevaux, E Fisher, G Hayem… - Arthritis care & …, 2007 - Wiley Online Library
Objective. To describe characteristics and outcomes of vasculitides associated with
malignancies. Methods. The requirement for inclusion in this retrospective, 10-year study was …

Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases

…, A Meulemans, R Lebtahi, G Hayem… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Ciprofloxacin labeled with 99m Tc specifically binds to various bacteria. Thus, it potentially
constitutes a specific marker allowing discrimination between septic arthritis/osteomyelitis and …